---
title: Meet HUB Organoids at Digestive Disease Week 2025
description: "Connect with HUB at Digestive Disease Week 2025: Visit our booth 4497, explore our latest scientific posters, and engage with our captivating spotlight talks."
image: https://resources.huborganoids.nl/hubfs/SocialMedia-DDW-2025-1080x1080.jpg
---

[![Logo HUB Organoids](https://resources.huborganoids.nl/hubfs/raw_assets/public/HUBOrganoids_May2021/images/logo-huborganoids-white.svg "Logo HUB Organoids")](https://huborganoids.nl/)

![merk-m-logo-blue](https://resources.huborganoids.nl/hs-fs/hubfs/merk-m-logo-blue.png?width=728&height=225&name=merk-m-logo-blue.png)

# Meet HUB Organoids at Digestive Disease Week 2025

Booth #4497

May 3-6, 2025  
San Diego, CA

![](https://resources.huborganoids.nl/hs-fs/hubfs/assets2024/ddw25-logo.png?width=300&name=ddw25-logo.png)

### Request a meeting

**Go with Your Gut: Join the Next Wave in Gastrointestinal Research with Organoid Technology**

Ever since the FDA Modernization Act, the translational potential of patient-derived organoids (PDOs) in gastrointestinal research has taken center stage. From inflammatory bowel disease (IBD) to novel co-culture systems integrating immune and gut epithelial cells, the field is primed to incorporate this cutting-edge technology into drug development pipelines. Curious about making the leap? Our team will be there to answer all your scientific and technical questions.

book a meeting

### Join Our Scientists at Digestive Disease Week

![](https://resources.huborganoids.nl/hs-fs/hubfs/assets2024/icon-clock.png?width=30&name=icon-clock.png) 6th May 2025 | 12:30-01:30 PM  
![](https://resources.huborganoids.nl/hs-fs/hubfs/Assets%202022/icon-location.png?width=30&name=icon-location.png) Halls C-E, Lower Level (SDCC)  
![](https://resources.huborganoids.nl/hs-fs/hubfs/assets2024/icon-marketing.png?width=30&name=icon-marketing.png) Emerging Tools and Technologies and *In Vivo* Models of GI Diseases

![](https://resources.huborganoids.nl/hs-fs/hubfs/assets2024/7626.png?width=150&name=7626.png)   
3D *In-Vitro* Fibroblast-Patient Derived Organoid Co-Culture: A High-Throughput Platform for IBD Drug Development

![](https://resources.huborganoids.nl/hs-fs/hubfs/assets2024/7821.png?width=150&name=7821.png)   
Patient Derived Organoid Monolayers: A Physiologically Relevant Platform for Evaluating Therapeutic Modalities in IBD

![](https://resources.huborganoids.nl/hs-fs/hubfs/assets2024/7935.png?width=150&name=7935.png)   
Reconstructing Tumor Microenvironment with Patient-Derived Organoids for De-risking Immuno-Oncology Therapies

request a meeting

![Logo HUB Organoids](https://resources.huborganoids.nl/hubfs/raw_assets/public/HUBOrganoids_May2021/images/logo-huborganoids-white.svg "Logo HUB Organoids")

[Privacy Policy](https://huborganoids.nl/privacy-policy)

HUB Organoids is now part of the Life Science Business of Merck KGaA, Darmstadt, Germany

***FOR RESEARCH USE ONLY.**  Unless otherwise stated in our catalog or other company documentation  
 accompanying the product(s), our products are intended for research use only and are not to be used   
 for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro   
 diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to   
humans or animals.*